Cite

HARVARD Citation

    Adam, S. et al. (n.d.). OP0076 JAK-INHIBITORS TOFACITINIB AND BARICITINIB IMPROVE PATHOLOGICAL BONE LOSS IN VIVO. Annals of the rheumatic diseases. p. 110. [Online]. 
  
Back to record